Page 16 - Karolinska Institutet

Genetics

New genetic clues for multiple sclerosis risk

An international team of researchers led by Karolinska Institutet in Sweden reports that cells in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) ...

Diseases, Conditions, Syndromes

Persistent T cell response to omicron after infection and vaccination

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, scientists at Karolinska Institutet in Sweden ...

Oncology & Cancer

New opportunities for targeting overactive cancer genes

Anita Göndör's group has identified a new mechanism underlying the pathological over-expression of cancer genes. The results, which are published in Nature Communications show that signals in the environment of the cancer ...

Oncology & Cancer

New immunotherapy for leukemia discovered

Researchers at Karolinska Institutet, University of Oslo and Oslo University Hospital have developed a new kind of immunotherapy for leukemia. The results of a study published in Nature Biotechnology show that the therapy ...

Cardiology

New way to identify early risks of cardiovascular disease

The risk of developing cardiovascular disease is strongly associated with the "bad" LDL cholesterol. A large study by scientists at Karolinska Institutet now shows that two proteins that transport cholesterol particles in ...

Oncology & Cancer

New findings on bacteria that increase risk of pancreatic cancer

Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumors. Now for the first time, live bacteria from cystic pancreatic lesions that are precursors ...

page 16 from 40